By Dean Seal
Elicio Therapeutics has hired the former chief financial officer of Cidara Therapeutics to lead its strategy and finances.
The Boston-based Elicio said Monday that Preetam Shah has been appointed chief strategy and financial officer.
Shah will also serve as the biotechnology company's principal financial officer and principal accounting officer.
He most recently served as the chief financial officer and chief business officer of fellow biotech Cidara. Before that, Shah was the CFO for Brainstorm Cell Therapeutics and has held roles at Barclays Capital and Canaccord Genuity.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
March 24, 2025 07:46 ET (11:46 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。